Steve Schonfeld’s BioNTech BNTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.65M Buy
+16,746
New +$1.63M 0.01% 1278
2026
Q1
– Sell
-23,078
Closed -$2.2M – 2247
2025
Q4
$2.2M Buy
+23,078
New +$2.33M 0.01% 843
2024
Q1
– Sell
-13,677
Closed -$1.44M – 2083
2023
Q4
$1.44M Buy
13,677
+11,377
+495% +$1.15M 0.01% 912
2023
Q3
$250K Sell
2,300
-79,398
-97% -$8.78M ﹤0.01% 1357
2023
Q2
$8.82M Buy
+81,698
New +$9.19M 0.08% 371
2023
Q1
– Sell
-12,080
Closed -$1.81M – 2125
2022
Q4
$1.81M Buy
+12,080
New +$1.86M 0.02% 860
2022
Q3
– Sell
-34,795
Closed -$5.19M – 2958
2022
Q2
$5.19M Buy
+34,795
New +$5.32M 0.05% 458
2022
Q1
– Sell
-3,200
Closed -$825K – 2601
2021
Q4
$825K Buy
+3,200
New +$876K 0.01% 1025
2021
Q1
– Sell
-11,900
Closed -$970K – 1810
2020
Q4
$970K Sell
11,900
-8,916
-43% -$875K 0.01% 827
2020
Q3
$1.44M Sell
20,816
-33,784
-62% -$2.42M 0.03% 606
2020
Q2
$3.64M Buy
+54,600
New +$2.73M 0.09% 281

Other funds holding BNTX

Steve Schonfeld's BNTX Position: Q3 2026 in Review

Steve Schonfeld opened a new position in BioNTech (BNTX) in Q3 2026: 16,746 shares worth $1.65M. The stake represents 0.01% of the portfolio and ranks #1278 among its holdings. This is a return to the name: Steve Schonfeld previously reported a position in BNTX as recently as Q4 2025.

Steve Schonfeld first reported a position in BNTX in Q2 2020 and has held it in 11 quarters since. The position peaked at $8.82M in Q2 2023. 302 funds tracked by Wall St. Rank hold BNTX as of Q3 2026.

  • Steve Schonfeld held 16,746 shares of BioNTech worth $1.65M as of Q3 2026.
  • BioNTech was a new Steve Schonfeld position in Q3 2026.
  • BioNTech made up 0.01% of Steve Schonfeld's portfolio in Q3 2026, its #1278 holding.
  • Steve Schonfeld first reported a position in BioNTech in Q2 2020 and has held it in 11 quarters since.
  • Steve Schonfeld's BioNTech position peaked at $8.82M in Q2 2023.
  • 302 funds tracked by Wall St. Rank held BioNTech as of Q3 2026.

Based on Schonfeld Strategic Advisors's 13F filing for Q3 2026, filed 16 Nov 2026.